Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 3, 2011, Pages 243-248

  Espnes, Marte Gravseth ^a   Bjørge, Tone ^a,b   Engeland, Anders ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cohort; Drug prescriptions; Medical birth registry; Population based registries

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; AGENTS AFFECTING METABOLISM; ANTI ACNE AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ANTIVITAMIN K; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAMASE INHIBITOR; CARDIOVASCULAR AGENT; DERMATOLOGICAL AGENT; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GASTROINTESTINAL AGENT; GLUCOCORTICOID; IMMUNOMODULATING AGENT; INSECT REPELLENT; INSECTICIDE; INSULIN; INSULIN DERIVATIVE; LITHIUM; PENICILLIN G; RESPIRATORY TRACT AGENT; RETINOID; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE;

ADULT; ARTICLE; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MEDICAL BIRTH REGISTRY; NORWAY; PREDICTIVE VALUE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; THIRD TRIMESTER PREGNANCY;

BIRTH CERTIFICATES; COHORT STUDIES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MEDICAL RECORDS; NORWAY; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PREGNANCY OUTCOME; REGISTRIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79951989916     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2085     Document Type: Article

References (15)

1. Irgens LM, The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79: 435-439.
2. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338: 1128-1137.
3. Lie RT. Studier av årsaker til medfødte misdannelser basert på Medisinsk fødselsregister. Nor J Epidemiol 2007; 17: 141-146.
4. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: Part 2. Drugs with minimal or unknown human teratogenic effect. Obstet Gynecol 2009; 113: 417-432.
5. Collaborative Group on Drug Use in Pregnancy. Drug use in pregnancy: a preliminary report of the International co-operative drug utilization study. Pharmaceutisch Weekblad 1990; 12: 75-78.
6. Ehrenstein V, Sørensen HT, Bakketeig LS, et al. Medical databases in studies of drug teratogenicity: methodological issues. Clin Epidemiol 2010; 2: 37-43.
7. Koren G. Ethical framework for observational studies of medicinal drug exposure in pregnancy. Teratology 2002; 65: 191-195.
8. Engeland A, Bramness JG, Daltveit AK, et al. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106, 000 pregnancies in Norway 2004-06. Br J Clin Pharmacol 2008; 69: 653-660.
9. Gagne JJ, Maio V, Berghella V, et al. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol 2008; 64: 1125-1132.
10. Olesen C, Søndergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology 2001; 12: 497-501.
11. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 2008; 18: 129-136.
12. WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs 2010. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2010.
13. Briggs G, Freeman R, Yaffe S. Drugs in Pregnancy & Lactation, 8th edn. Lippincott, Williams & Wilkins: Wolters Kluwer, 2008.
14. Malm H, Martikainen J, Klaukka T, et al. Prescription drugs during pregnancy and lactation-a Finnish register-based study. Eur J Clin Pharmacol 2003; 59: 127-133.
15. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40: 1723-1733.